The science of a more personal future
Our ambition is a human virtual twin for every person: a biological reference that evolves over time and helps bring personalized, precise and proactive medicine within reach.
The BioTwin method
BioTwin brings advanced measurement and proprietary modeling together. The result is a connected representation of your biology, designed to gain context with every new observation.
Explore the full presentation
At-home sampling and personal context provide the starting point. Repeat collections create a history of your biology.
Analytical chemistry, including high-resolution mass spectrometry and metabolomics, examines the small molecules that reflect biological activity.
Advanced analytics connect related signals into proprietary Bio-Signatures, making complex biological patterns easier to explore.
BioTwin's virtual model brings those patterns together with your context. New observations update your personal reference and reveal the story across time.
The wider research landscape
Beyond the first medical roadmap, BioTwin's research explores connections across oncology, neurology, cardiovascular function, women's health, fatigue and metabolism.
A more personal approach to early detection.
Breast · Colorectal · Lung · Pancreatic · Prostate · Ovarian
Cancer Bio-Signatures lead the medical roadmap, with breast and colorectal applications at the forefront of the UAE clinical pathway.
Explore oncologyNew insight into complex neurological conditions.
Parkinson's · Dementia · Depression · Epilepsy
Research explores whether metabolic patterns can add useful biological context to conditions that are often difficult to characterize.
Explore neurologyUnderstand the biology behind cardiovascular change.
Heart failure · Hypertension
Cardiovascular research extends the platform toward a more personal view of risk, physiological change and clinical follow-up.
Explore cardiologyConnect the systems that shape everyday health.
Pre-diabetes & obesity · Women's health · Allergy, immunity & sensitivity · ME/CFS
These programs explore the links between metabolism, symptoms, lifestyle and longer-term health.
Explore the researchThese are research and development areas. Medical access is currently through participating physicians in the United Arab Emirates.
The horizon
Our vision reaches from recognizing meaningful biological change to supporting more personal care, exploring individual responses and, ultimately, testing possibilities in a virtual representation of you.
Today, the same technological foundation also powers TwinMe programs for people who want to explore their biology and take an active role in their health.
The evidence, in depth
Publications and announcements, with the question studied and the stage of validation.
BioTwin's foundational paper describes the Human Virtual Twin framework and individual biological profiling. It establishes the technology's scientific foundation and the idea of a personal biological reference.
Read the journal articleA peer-reviewed study of 1,257 participants, 18,288 samples and 134 analytical batches identifies individuals from their metabolic profiles with 94% user-level accuracy. It addresses biological individuality and repeat measurement.
Read the journal articleA retrospective case-control study includes 2,734 participants: 114 diagnosed breast cancer cases and 2,620 controls. It investigates breast cancer-associated metabolic signatures and identifies prospective evaluation in asymptomatic populations as a next step.
Read the preprintAn exploratory cohort study examines metabolic patterns associated with self-reported post-exertional malaise-like fatigue in 1,784 participants, adding to BioTwin's research beyond oncology.
Read the preprintThe institutional announcement describes Cleveland Clinic Abu Dhabi's collaboration with BioTwin on a breast cancer pilot. It records Department of Health approval for research purposes at that date. The current medical access pathway is described separately on BioTwin's oncology pages.
Read the institutional announcementPreprints present research before peer review. Dates above refer to the publicly posted version.
BioTwin’s public ecosystem
Medical research, public support and technology expertise all play a part in bringing human virtual twins into the world.
Harvard Medical School
Cleveland Clinic Abu Dhabi
Concordia University
Institut de Cardiologie de Québec
Al Jalila Hospital
Department of Health, Abu Dhabi
CED, Canada Economic Development
NRC IRAP
Investissement Québec
Ville de Québec
MBRIF
Mubadala
Hub71
Le Camp
Microsoft for Startups
Microsoft Entrepreneurship for Positive Impact
Google for Startups
NVIDIA Inception
AWS
IBM
Novo Nordisk
KPMG
Fasken
QuantinoOrganizations presented in BioTwin's public ecosystem. Specific roles and sources are detailed below.
Organizations and programs presented in BioTwin's public ecosystem. The documented breast cancer pilot with Cleveland Clinic Abu Dhabi and its research authorization are described in the institutional announcement.
Breast cancer research pilot
A clinical collaboration announced on 31 January 2025.
Research authorization
The 2025 announcement records approval for the pilot for research purposes.
In the news
Explore television reports, interviews and journalism about BioTwin, its technology and its medical ambition. Coverage is primarily in French.
